L22. Crescent formation: unraveling local mediators that break glomerular epithelial cell tolerance to immune injury.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Presse medicale

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lpm.2013.01.021PMID 23474044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis.

  2012cited by this paper
• Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.

  2012cited by this paper
• Progress in treatment of ANCA-associated vasculitis

  2012cited by this paper
• Epidermal growth factor: a new therapeutic target in glomerular disease.

  2012cited by this paper
• Targeting signaling pathways in glomerular diseases

  2012cited by this paper
• Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.

  2012cited by this paper
• EGFR signaling in podocytes at the root of glomerular disease

  2011cited by this paper
• Erratum: Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis

  2011cited by this paper
• Histopathologic classification of ANCA-associated glomerulonephritis.

  2010cited by this paper
• De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

  2010influential reference
• Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.

  2009influential reference
• Podocytes contribute to the formation of glomerular crescents.

  2008cited by this paper
• Recurrent glomerulonephritis after renal transplantation: an unsolved problem.

  2008cited by this paper
• Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis

  2007cited by this paper
• Coût de la prise en charge de la dialyse en France

  2007cited by this paper
• Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.

  2007cited by this paper
• [Cost of dialysis in France].

  2007cited by this paper
• Activated parietal epithelial cells or dedifferentiated podocytes in FSGS: can we make the difference?

  2006cited by this paper
• ANCA-negative pauci-immune renal vasculitis: histology and outcome.

  2005cited by this paper
• Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis.

  2004cited by this paper
• Alterations of podocytes in a murine model of crescentic glomerulonephritis

  2004cited by this paper
• Cell biology of the glomerular podocyte.

  2003cited by this paper
• PARticipation in inflammation.

  2003cited by this paper
• Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials.

  2003cited by this paper
• Populate Cellular Crescents in a Murine Model of Inflammatory Glomerulonephritis

  2003cited by this paper
• A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor*

  2001cited by this paper
• Goodpasture's disease.

  2001cited by this paper
• Long-Term Outcome of AntiGlomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression

  2001cited by this paper
• Protease-Activated Receptor 1 Mediates Thrombin-Dependent, Cell-Mediated Renal Inflammation in Crescentic Glomerulonephritis

  2000cited by this paper
• Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.

  1993cited by this paper

• Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies

  2024cites this paper